{"id":787818,"date":"2020-11-04T17:38:27","date_gmt":"2020-11-04T15:38:27","guid":{"rendered":""},"modified":"2020-11-05T11:40:53","modified_gmt":"2020-11-05T09:40:53","slug":"pryskorenyj-dostup-do-vaktsyn-vid-covid-19-bude-mozhlyvyj-v-ukrayini","status":"publish","type":"post","link":"https:\/\/new.eba.com.ua\/en\/pryskorenyj-dostup-do-vaktsyn-vid-covid-19-bude-mozhlyvyj-v-ukrayini\/","title":{"rendered":"Ukraine will have accelerated access to COVID-19 vaccines"},"content":{"rendered":"<p><span data-preserver-spaces=\"true\">Currently, there is a rapid increase in the incidence of COVID-19 in the world and in Ukraine. As there is currently no specific treatment, the rapid development of an effective and safe vaccine against COVID-19 and its early use is a vital measure to reduce the spread of infection and related morbidity and mortality.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Thus, according to the experts of the EBA Clinical Trials Subcommittee, the vaccines have the greatest potential to combat the COVID-19, therefore global pharmaceutical companies focus their research on vaccine development.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">According to the WHO, there are currently 198 vaccine candidates under development in the world, 42 of which are in the clinical stage of development. At the same time, there are more than 240 active clinical trials of vaccines worldwide. Unfortunately, Ukraine has not yet been included in any of these clinical trials of COVID-19 vaccines. This requires changes to Ukrainian legislation.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">The EBA Clinical Trials Subcommittee asked MPs to initiate changes to the legislation that would allow attracting international clinical trials of drugs to Ukraine not only for the treatment of patients with COVID-19 but also for the prevention of this disease, namely the creation and clinical study of vaccines, as well as to reduce the state registration of vaccines or other drugs for the prevention of coronavirus disease and extend the validity of these amendments to the Law of Ukraine \u2116539-IX until the end of the quarantine period.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Currently, the relevant <a href=\"http:\/\/w1.c1.rada.gov.ua\/pls\/zweb2\/webproc4_1?pf3511=70318\" target=\"_blank\" rel=\"noopener\">draft law<\/a> \u21164314 of November 4, 2020, has been registered in the Verkhovna Rada of Ukraine. The business would like to thank MPs and the authors of the draft law for their quick response to the challenges associated with the pandemic by preparing the draft and registering it. We hope for prompt consideration and approval of the draft law in the Verkhovna Rada.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">By attracting clinical trials of COVID-19 vaccines to Ukraine, it will be possible to vaccinate a certain part of the population of Ukraine against COVID-19 as a part of conducting such trials. In turn, the reduction of the term of state registration of vaccines from COVID-19 will help accelerate the full-scale use of effective and safe vaccines. Therefore, businesses hope to further support the draft law.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><em><span data-preserver-spaces=\"true\">For reference:<\/span><\/em><\/p>\n<p><span data-preserver-spaces=\"true\">The business community expresses its gratitude to:<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Ms. Olha Stefanyshyna &#8211; Member of the Verkhovna Rada Committee on Public Health, Medical Assistance and Medical Insurance<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Mr. Mykhailo Radutsky &#8211; Chairman of the Verkhovna Rada on Public Health, Medical Assistance and Medical Insurance<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Mr. Serhiy Kuzminykh &#8211; Chairman of the Subcommittee on Pharmacy and Pharmaceutical Activity of the Verkhovna Rada Committee on Public Health, Medical Assistance and Medical Insurance<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Mr. Yaroslav Yurchyshyn &#8211; First Deputy Chairman of the Verkhovna Rada Committee on Anti-Corruption Policy<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Mr. Yaroslav Zheleznyak &#8211; First Deputy Chairman of the Verkhovna Rada Committee on Finance, Tax and Customs Policy<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Ms. Tetyana Dumenko &#8211; Director of the State Expert Center of the Ministry of Health of Ukraine<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Ms. Kovtun Lyudmyla &#8211; Deputy Director for Clinical Affairs of the State Expert Center of the Ministry of Health of Ukraine<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">Lana Sinichkina &#8211; Partner, Attorney-at-Law, Artzinger<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">\u00a0\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><em>Be the first to learn about the latest EBA news with our Telegram-channel <\/em><em>\u2013 <\/em><a href=\"https:\/\/bit.ly\/3g6lO9b\" target=\"_blank\" rel=\"noopener\"><em>EBAUkraine<\/em><\/a><em>.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Currently, there is a rapid increase in the incidence of COVID-19 in the world and in Ukraine. As there is currently no specific treatment, the rapid development of an effective and safe vaccine against COVID-19 and its early use is a vital measure to reduce the spread of infection and related morbidity and mortality. Thus, [&hellip;]<\/p>\n","protected":false},"author":23406,"featured_media":296220,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[15573,15564,15563,15571],"tags":[],"class_list":["post-787818","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-kyiv-en","category-lobbying-news-en","category-main-news-en","category-press-releases-en"],"_links":{"self":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/787818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/users\/23406"}],"replies":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/comments?post=787818"}],"version-history":[{"count":0,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/787818\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/media\/296220"}],"wp:attachment":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/media?parent=787818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/categories?post=787818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/tags?post=787818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}